Glaukos Corp
NYSE:GKOS

Watchlist Manager
Glaukos Corp Logo
Glaukos Corp
NYSE:GKOS
Watchlist
Price: 138.62 USD -3.23% Market Closed
Market Cap: 7.6B USD
Have any thoughts about
Glaukos Corp?
Write Note

Glaukos Corp
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glaukos Corp
Total Liabilities & Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Glaukos Corp
NYSE:GKOS
Total Liabilities & Equity
$926.5m
CAGR 3-Years
-5%
CAGR 5-Years
25%
CAGR 10-Years
43%
Becton Dickinson and Co
NYSE:BDX
Total Liabilities & Equity
$57.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
16%
Boston Scientific Corp
NYSE:BSX
Total Liabilities & Equity
$38.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Total Liabilities & Equity
$43.8B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Liabilities & Equity
$73B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Liabilities & Equity
$17.7B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
17%

See Also

What is Glaukos Corp's Total Liabilities & Equity?
Total Liabilities & Equity
926.5m USD

Based on the financial report for Sep 30, 2024, Glaukos Corp's Total Liabilities & Equity amounts to 926.5m USD.

What is Glaukos Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
43%

Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Glaukos Corp have been -5% over the past three years , 25% over the past five years , and 43% over the past ten years .

Back to Top